The Lupus Research Alliance (LRA) has announced $9 million in grants awarded to international research teams from 14 institutions as part of its Global Team Science Award (GTSA).

GTSA, which was stablished and funded by a grant from Bloomberg Philanthropies, provides $3 million over three years to multidisciplinary teams in support of interdisciplinary, collaborative, and highly synergistic projects that use groundbreaking technologies to accelerate effective, personalized lupus treatments.

The 2022 GTSA will enable the work of teams headed by lupus researchers Betty Diamond, director of the Institute of Molecular Medicine and Maureen and Ralph Nappi Professor of Autoimmune Diseases, Feinstein Institutes for Medical Research (United States); Martin Kriegel, chief of rheumatology and head of the Department of Translational Rheumatology and Immunology at the University of Münster (Germany); and Eric Morand, head of the School of Clinical Sciences, Monash University (Australia).

“We are thrilled to add three new and exciting programs to our Global Team Science Award,” said LRA chief scientific officer Teodora Staeva. “These three projects, selected from many compelling proposals, explore underlying causes of lupus heterogeneity and set the foundation for the future personalization of lupus treatments.” 

For a complete list of the research teams and their focus areas, see the LRA website. 

(Photo credit: Getty Images/manusapon kasosod)